---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009401"
form_type: "8-K"
ticker: "NXTC"
cik: "0001661059"
company_name: "NextCure, Inc."
filed_at: "2024-06-21T23:59:59+00:00"
generated_at: "2026-06-01T02:52:30.216196+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# NextCure shareholders reject officer exculpation amendment at 2024 annual meeting

## Summary
- Proposal to amend charter to exculpate officers failed: 10,638,433 for, 2,863,486 against, 11,212 abstain.
- Elaine V. Jones and Ellen G. Feigal elected as Class II directors with 11.8M and 12.9M votes for, respectively.
- Ernst & Young LLP ratified as independent auditor for FY2024: 21,818,499 for, 98,189 against.
- Broker non-votes of 8,403,929 on director election and exculpation proposals.

## SEC filing metadata
- accession: 0001558370-24-009401
- form_type: 8-K
- ticker: NXTC
- cik: 0001661059
- company_name: NextCure, Inc.
- filed_at: 2024-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1661059/000155837024009401/0001558370-24-009401-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1661059/000155837024009401/nxtc-20240620x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009401
- JSON: https://secwatch.observer/filing/0001558370-24-009401.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009401.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.